Therapeutic interventions for fructose-induced fatty liver disease are premature


  • Potential conflict of interest: The author is a consultant to the food and beverage industry in the area of nutritive sweeteners. His clients include research institutes, food industry councils, trade organizations, and individual companies.

No abstract is available for this article.